Hemolysis is conventionally defined as membrane disruption of red blood cells and other
blood cells that is accompanied by subsequent release of intracellular components into the …

Sažetak Laboratory analyses are crucial for diagnosis, follow-up and treatment decisions.
Since mistakes in every step of the total testing process may potentially affect patient safety …

Objectives Hemolysis, icterus, and lipemia (HIL) are common sources of endogenous
interference in clinical laboratory testing. Defining the threshold of interference for …

In order to guarantee patient safety, medical laboratories around the world strive to provide
highest quality in the shortest amount of time. A major leap in quality improvement was …

Clinical prediction of underlying pathologic substrates in people with Alzheimer's disease
(AD) dementia or related dementia syndromes (ADRD) has limited accuracy. Etiologic …

Since the beginning of laboratory medicine, the main focus was to provide high quality
analytics. Over time the importance of the extra-analytical phases and their contribution to …

Objectives Lipemia is the presence of abnormally high lipoprotein concentrations in serum
or plasma samples that can interfere with laboratory testing. There is little guidance …

Sažetak Introduction: Compared to other activities of the testing process, the preanalytical
phase is plagued by a lower degree of standardization, which makes it more vulnerable to …

Purpose: Therapeutic drug monitoring (TDM) is a well-established tool for guiding
psychopharmacotherapy and improving patient care. Despite their established roles in the …

Introduction Hemolysate in plasma samples from patients may cause misleading results in
coagulation assays. Even though modern coagulation instruments often are equipped with …